AKT1 and neoplasm: β-Elemene was proved to effectively inhibit the viability of various tumor cells, including human NSCLC A549 cells, gastric cancer MGC803 and SGC7901 cells, and renal-cell carcinoma 786-0 cells by suppressing the PI3K/AKT/mTOR signaling pathway.